These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
689 related items for PubMed ID: 24014598
1. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598 [Abstract] [Full Text] [Related]
2. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. Urban M, Banks E, Egger S, Canfell K, O'Connell D, Beral V, Sitas F. PLoS Med; 2012 Nov; 9(3):e1001182. PubMed ID: 22412354 [Abstract] [Full Text] [Related]
3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB, Porterfield D. Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340 [Abstract] [Full Text] [Related]
5. [Use of oral contraceptives and risk of cancer, a cohort study]. Kumle M, Alsaker E, Lund E. Tidsskr Nor Laegeforen; 2003 Jun 12; 123(12):1653-6. PubMed ID: 12821980 [Abstract] [Full Text] [Related]
6. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives. Jordan SJ, Wilson LF, Nagle CM, Green AC, Olsen CM, Bain CJ, Pandeya N, Whiteman DC, Webb PM. Aust N Z J Public Health; 2015 Oct 12; 39(5):441-5. PubMed ID: 26437729 [Abstract] [Full Text] [Related]
7. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. Michels KA, Pfeiffer RM, Brinton LA, Trabert B. JAMA Oncol; 2018 Apr 01; 4(4):516-521. PubMed ID: 29346467 [Abstract] [Full Text] [Related]
8. Oral contraceptives and gynecologic cancer: an update for the 1990s. Kaunitz AM. Am J Obstet Gynecol; 1992 Oct 01; 167(4 Pt 2):1171-6. PubMed ID: 1415442 [Abstract] [Full Text] [Related]
10. Oral contraceptive use for the primary prevention of ovarian cancer. Havrilesky LJ, Gierisch JM, Moorman PG, Coeytaux RR, Urrutia RP, Lowery WJ, Dinan M, McBroom AJ, Wing L, Musty MD, Lallinger KR, Hasselblad V, Sanders GD, Myers ER. Evid Rep Technol Assess (Full Rep); 2013 Jun 01; (212):1-514. PubMed ID: 24423062 [Abstract] [Full Text] [Related]
11. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study. Vessey M, Yeates D. Contraception; 2013 Dec 01; 88(6):678-83. PubMed ID: 24090961 [Abstract] [Full Text] [Related]
12. Oral contraceptives and reproductive system cancer. Deligeoroglou E, Michailidis E, Creatsas G. Ann N Y Acad Sci; 2003 Nov 01; 997():199-208. PubMed ID: 14644827 [Abstract] [Full Text] [Related]
20. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers. Karlsson T, Johansson T, Höglund J, Ek WE, Johansson Å. Cancer Res; 2021 Feb 15; 81(4):1153-1162. PubMed ID: 33334812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]